Advances in colon-targeted nano-drug delivery systems: challenges and solutions

Muhammad Naeem1,2, Uzma Azeem Awan1, Fazli Subhan1

  • 1Department of Biological Sciences, National University of Medical Sciences, Rawalpindi, Punjab, Pakistan.

Insights

Nano-drug delivery systems (NDDS) offer targeted colon delivery for diseases like ulcerative colitis and colon cancer. Advances in NDDS aim to overcome challenges for efficient, localized treatment with reduced systemic toxicity.

Area of Science:

  • Nanomedicine
  • Gastroenterology
  • Drug Delivery

Background:

  • Nano-drug delivery systems (NDDS) are crucial for treating colon-specific diseases like ulcerative colitis, Crohn's disease, and colon cancer.
  • Targeted delivery enhances therapeutic efficacy and reduces systemic toxicity by concentrating treatments in diseased colon areas.
  • Challenges include premature drug release, degradation in the stomach, pH variations, mucus entrapment, and upper intestinal uptake.

Purpose of the Study:

  • To review potential applications of colon-specific drug delivery systems.
  • To identify and discuss challenges associated with orally administered colon-targeted delivery systems.
  • To summarize recent advancements and future prospects in orally administered NDDS for colon targeting.

Main Methods:

  • Literature review of scientific publications on colon-targeted nano-drug delivery.
  • Analysis of challenges and recent advancements in NDDS for oral administration.
  • Synthesis of information on the development and future of colon-specific drug delivery.

Main Results:

  • NDDS show promise for localized treatment of colon diseases, improving drug efficacy and reducing side effects.
  • Significant hurdles remain, including physiological barriers in the gastrointestinal tract that can compromise delivery.
  • Recent innovations are emerging to address these challenges, paving the way for more effective colon-targeted therapies.

Conclusions:

  • Despite challenges, advancements in NDDS offer significant potential for improved colon-specific drug delivery.
  • Overcoming barriers like degradation and premature release is key to successful therapeutic outcomes.
  • Continued research into NDDS is vital for developing efficient treatments for colon disorders.

Related Concept Videos

Drug Delivery: Overview01:16

Drug Delivery: Overview

The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
663
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
145
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
149
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems01:22

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
118
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
676